Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Indivior PLC INVVY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
62/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Indivior PLC (INVVY) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is neutral — 1 Hold.

INVVY Analyst Ratings

Hold
1
Ratings
1 Hold
Based on 1 analysts giving stock ratings to Indivior PLC in the past 3 months
Rating breakdown
Hold
1 100%
0%
Buy
0 analysts
100%
Hold
1 analysts
0%
Sell
0 analysts

People Also View

ITCI
ITCI
Intra-Cellular Therapies, Inc.
$131.87
+0.00%
 NBIX
NBIX
Neurocrine Biosciences, Inc.
$131.44
+0.48%
 ELAN
ELAN
Elanco Animal Health Incorporated
$23.23
-3.65%
 CTLT
CTLT
Catalent, Inc.
$63.48
+0.00%
 ALKS
ALKS
Alkermes plc
$33.22
-1.92%
 DNPUF
DNPUF
Sumitomo Pharma Co., Ltd.
$11.11
+0.00%
 HYPMY
HYPMY
Hypera S.A.
$4.67
-0.97%
 ANIP
ANIP
ANI Pharmaceuticals, Inc.
$76.48
-2.31%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message